April 24, 2025 U.S. Equities Mobileye soothes tariff fears with strong second-quarter revenue forecast Read more
April 24, 2025 U.S. Equities Mobileye soothes tariff fears with strong second-quarter revenue forecast Read more
April 24, 2025 U.S. Equities Bristol Myers posts higher-than-expected quarterly revenue on cancer drug sales Read more
April 24, 2025 U.S. Equities Denmark stocks lower at close of trade; OMX Copenhagen 20 down 0.11% Read more
April 24, 2025 U.S. Equities American Airlines pulls 2025 forecast on travel demand worries from Trump tariffs Read more
April 24, 2025 U.S. Equities FDA approves Akeso Biopharma’s new drug for nasopharyngeal carcinoma treatment Read more
April 24, 2025 U.S. Equities Trump calls on Boeing to default China for halting airplane delivery acceptance Read more